CTSO
Cytosorbents Crp
NASDAQ: CTSO · HEALTHCARE · MEDICAL DEVICES
$0.57
-5.80% today
Updated 2026-05-06
Market cap
$38.95M
P/E ratio
—
P/S ratio
1.05x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$1 – $1
Volume
0.1M
Cytosorbents Crp (CTSO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $36078.00 | $151574.00 | $821787.00 | $3.15M | $4.06M | $8.21M | $13.38M | $20.25M | $22.77M | $39.45M | $40.11M | $34.69M | $31.08M | $35.59M | $37.06M |
| Revenue growth (YoY) | — | — | — | — | — | — | +320.1% | +442.2% | +282.7% | +29.0% | +102.3% | +63.1% | +51.3% | +12.4% | +73.3% | +1.7% | -13.5% | -10.4% | +14.5% | +4.1% |
| Cost of revenue | — | — | — | — | — | $11760.00 | $319298.00 | $1.91M | $2.13M | $2.21M | $3.95M | $5.52M | $7.49M | $7.36M | $11.05M | $11.05M | $13.96M | $9.13M | $10.47M | $10.57M |
| Gross profit | — | — | — | — | — | $24318.00 | $-167724.00 | $-1.09M | $1.01M | $1.84M | $4.25M | $7.86M | $12.76M | $15.40M | $28.40M | $29.06M | $20.73M | $21.95M | $25.13M | $26.49M |
| Gross margin | — | — | — | — | — | 67.4% | -110.7% | -132.6% | 32.1% | 45.4% | 51.8% | 58.8% | 63.0% | 67.7% | 72.0% | 72.5% | 59.8% | 70.6% | 70.6% | 71.5% |
| R&D | $1.11M | $1.42M | $1.98M | $1.96M | $1.76M | $2.89M | $2.53M | $1.74M | $2.43M | $3.87M | $4.78M | $4.05M | $7.72M | $12.09M | $8.81M | $16.38M | $15.12M | $15.59M | $6.92M | $5.08M |
| SG&A | $939128.00 | $1.65M | $909372.00 | $757450.00 | $1.07M | $1.57M | $1.98M | $3.49M | $6.84M | $8.01M | $12.28M | $15.43M | $22.88M | $24.47M | $31.51M | $38.48M | $2.21M | $37.87M | $35.00M | $35.65M |
| Operating income | $-2.96M | $-3.07M | $-3.24M | $-2.43M | $-2.82M | $-4.44M | $-3.49M | $-4.71M | $-7.28M | $-9.30M | $-11.49M | $-9.84M | $-15.58M | $-18.97M | $-10.37M | $-22.74M | $-31.52M | $-31.95M | $-16.79M | $-14.24M |
| Operating margin | — | — | — | — | — | -12297.7% | -2303.1% | -573.5% | -231.4% | -229.4% | -140.0% | -73.6% | -77.0% | -83.3% | -26.3% | -56.7% | -90.9% | -102.8% | -47.2% | -38.4% |
| EBITDA | $-1.74M | $-3.16M | $-3.14M | $-2.98M | $-2.81M | $-4.40M | $-3.44M | $-4.65M | $-7.21M | $-9.19M | $-11.86M | $-8.17M | $-15.98M | $-18.39M | $-9.71M | $-21.62M | $-30.00M | $-27.88M | $-15.22M | $-12.74M |
| EBITDA margin | — | — | — | — | — | -12185.1% | -2267.0% | -565.7% | -229.4% | -226.6% | -144.6% | -61.1% | -78.9% | -80.8% | -24.6% | -53.9% | -86.5% | -89.7% | -42.7% | -34.4% |
| EBIT | $-3.00M | $-3.35M | $-3.24M | $-3.03M | $-2.82M | $-4.44M | $-3.49M | $-4.71M | $-7.28M | $-9.30M | $-12.03M | $-8.39M | $-16.37M | $-18.97M | $-10.37M | $-22.74M | $-30.89M | $-29.90M | $-16.79M | $-14.24M |
| Interest expense | $4.74M | $3.35M | $22207.00 | $8142.00 | $84846.00 | $1.04M | $564428.00 | $422843.00 | $310024.00 | $9301.00 | $231804.00 | $749076.00 | $1.46M | $1.03M | $1.20M | $4.00M | $132597.00 | $157891.00 | $1.40M | $2.61M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.67M | $-3.35M | $-3.02M | $-2.74M | $-2.91M | $-5.48M | $-3.66M | $-4.68M | $-9.32M | $-8.13M | $-11.94M | $-8.46M | $-17.21M | $-19.27M | $-7.84M | $-24.56M | $-32.81M | $-29.25M | $-20.72M | $-8.20M |
| Net income growth (YoY) | — | +56.3% | +9.9% | +9.3% | -6.3% | -88.4% | +33.2% | -27.7% | -99.3% | +12.8% | -46.8% | +29.1% | -103.4% | -11.9% | +59.3% | -213.4% | -33.6% | +10.9% | +29.2% | +60.4% |
| Profit margin | — | — | — | — | — | -15193.9% | -2417.0% | -569.2% | -296.4% | -200.5% | -145.5% | -63.2% | -85.0% | -84.6% | -19.9% | -61.2% | -94.6% | -94.1% | -58.2% | -22.1% |